BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 4673237)

  • 1. Studies on the product of the reaction between activated Hageman factor (factor XII) and plasma thromboplastin antecedent (factor XI).
    Ratnoff OD
    J Lab Clin Med; 1972 Nov; 80(5):704-10. PubMed ID: 4673237
    [No Abstract]   [Full Text] [Related]  

  • 2. Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.
    Ratnoff OD; Saito H
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):958-61. PubMed ID: 284420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells.
    Wiggins RC; Loskutoff DJ; Cochrane CG; Griffin JH; Edgington TS
    J Clin Invest; 1980 Jan; 65(1):197-206. PubMed ID: 6444222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgE-induced blood coagulation alterations in the rabbit: consumption of coagulation factors XII, XI, and IX in vivo.
    Pinckard RN; Tanigawa C; Halonen M
    J Immunol; 1975 Aug; 115(2):525-32. PubMed ID: 50367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rabbit blood coagulation factor XI. Mechanism of activation of rabbit Hageman factor (factor XII).
    Wiggins RC; Cochrane CG; Griffin JH
    Thromb Res; 1979; 15(3-4):487-95. PubMed ID: 494157
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolation of prekallikrein activator from guinea pig serum or plasma adsorbed to immune precipitates or celite: possible relationship to Hageman factor.
    Treloar MP; Pyle H; Ozge-Anwar AH; Takeuchi Y; Movat HZ
    Eur J Immunol; 1972 Aug; 2(4):338-45. PubMed ID: 5083514
    [No Abstract]   [Full Text] [Related]  

  • 7. Activation of human factor XI (plasma thromboplastin antecedent) by factor XIIa (activated Hageman factor).
    Kurachi K; Davie EW
    Biochemistry; 1977 Dec; 16(26):5831-9. PubMed ID: 588558
    [No Abstract]   [Full Text] [Related]  

  • 8. [Behavior of surface-sensitive coagulation factors XII and XI in intravasal coagulation].
    Müller-Berghaus G; Ehlers E; Käufer P
    Verh Dtsch Ges Inn Med; 1974; 80():1458-60. PubMed ID: 4454455
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood coagulation. Role of Hageman protein (F-XII) and autoprothrombin II (F-IX?) in the activation of autoprothrombin 3 (F-X).
    Seegers WH; Grammens GL; McCoy LE
    Thromb Diath Haemorrh; 1970 Dec; 24(3):345-51. PubMed ID: 5533980
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hageman factor. Present-day views].
    Ratajczak T; Szewczyk Z
    Postepy Hig Med Dosw; 1978; 32(3):291-309. PubMed ID: 714825
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on plasma thromboplastin antecedent (factor XI), PTA deficiency and inhibition of PTA by plasma: pharmacologic inhibitors and specific antiserum.
    Forbes CD; Ratnoff OD
    J Lab Clin Med; 1972 Jan; 79(1):113-27. PubMed ID: 4257309
    [No Abstract]   [Full Text] [Related]  

  • 12. Contact activation of Hageman factor and the interaction of Hageman factor and plasma thromboplastin antecedent.
    Haanen C; Morselt G; Schoenmakers J
    Thromb Diath Haemorrh; 1967 May; 17(3-4):307-20. PubMed ID: 5626768
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent.
    RATNOFF OD; DAVIE EW; MALLETT DL
    J Clin Invest; 1961 May; 40(5):803-19. PubMed ID: 13739760
    [No Abstract]   [Full Text] [Related]  

  • 14. Partial purification and some properties of a plasma inhibitor of activated plasma thromboplastin antecedent (factor XI).
    Amir J; Ratnoff OD; Pensky J
    J Lab Clin Med; 1972 Dec; 80(6):786-802. PubMed ID: 4673715
    [No Abstract]   [Full Text] [Related]  

  • 15. Partial purification of plasma thromboplastin antecedent (factor XI) and its activation by trypsin.
    Saito H; Ratnoff OD; Marshall JS; Pensky J
    J Clin Invest; 1973 Apr; 52(4):850-61. PubMed ID: 4266422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inflammatory process in acute gouty arthritis. II. The presence of Hageman factor and plasma thromboplastin antecedent in synovial fluid.
    Kellermeyer RW; Breckenridge RT
    J Lab Clin Med; 1966 Mar; 67(3):455-60. PubMed ID: 5910152
    [No Abstract]   [Full Text] [Related]  

  • 17. Theories of blood coagulation. Properties and interactions of blood clotting factors.
    Kazal LA
    Ann Clin Lab Sci (1971); 1971; 1(2):139-54. PubMed ID: 4949446
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator.
    Forbes CD; Pensky J; Ratnoff OD
    J Lab Clin Med; 1970 Nov; 76(5):809-15. PubMed ID: 5477337
    [No Abstract]   [Full Text] [Related]  

  • 19. The importance of surfaces in contact phase reactions.
    Vroman L
    Semin Thromb Hemost; 1987 Jan; 13(1):79-85. PubMed ID: 3551077
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of thorium dioxide upon blood clotting and platelets. I. In vitro studies.
    Hjort PF; McGehee WG; Rapaport SI
    Thromb Diath Haemorrh; 1966 Dec; 16(3):333-53. PubMed ID: 5996663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.